Yang Peng

发表

PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.

G. Mills, Z. Ju, Wei Zhao, 2018, Cancer research.

Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.

P. Brown, G. Peng, W. Tu, 2017, DNA repair.

Dissect the Dynamic Molecular Circuits of Cell Cycle Control through Network Evolution Model

G. Peng, R. Tao, P. Scott, 2017, BioMed research international.

TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

E. Wang, G. Peng, Shiaw-Yih Lin, 2015, Cancer research.

Genome-wide Transcriptome Profiling of Homologous Recombination DNA Repair

G. Mills, S. Hanash, Ju-Seog Lee, 2014, Nature Communications.

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.

Wei Zhang, G. Mills, P. Brown, 2015, Cancer discovery.

Tumor Suppressor ARID1A Deficiency Impairs DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

P. Brown, G. Peng, L. Zou, 2018 .

mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer

G. Mills, G. Peng, F. Meric-Bernstam, 2015, Clinical Cancer Research.

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.

G. Mills, J. Ajani, Z. Ju, 2020, The Journal of clinical investigation.

Inhibition of the ATM / Chk 2 axis promotes cGAS / STING signaling in ARID 1 A-deficient tumors

G. Mills, J. Ajani, Z. Ju, 2020 .

Identifying Cell Cycle Modulators That Selectively Target ARID1A Deficiency Using High-Throughput Image-Based Screening

P. Brown, G. Peng, K. Tao, 2017, SLAS discovery : advancing life sciences R & D.

ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade

G. Mills, J. Ajani, Z. Ju, 2018, Nature Medicine.

Mismatch repair-based stratification for immune checkpoint blockade therapy.

G. Peng, Lihong Zhang, Yang Peng, 2018, American journal of cancer research.

ITCH nuclear translocation and H1.2 polyubiquitination negatively regulate the DNA damage response

G. Peng, Lufen Chang, B. Zhou, 2018, Nucleic acids research.

1 mTOR inhibitors suppress homologous recombination repair and synergize with PARP inhibitors via regulating SUV 39 H 1 in BRCA-proficient triple-negative breast cancer

G. Mills, G. Peng, F. Meric-Bernstam, 2015 .

Homologous repair deficiency in VHL-mutated clear cell renal cell carcinoma.

E. Jonasch, G. Peng, P. Pilié, 2018 .

Functional biomarkers of homologous repair (HR) deficiency to guide novel DNA damage response targeted therapy in clear cell renal cell carcinoma (ccRCC).

E. Jonasch, G. Peng, T. Yap, 2018 .

Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells

G. Peng, P. Sung, Surinder Kumar, 2017, Oncogenesis.

ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade

G. Mills, J. Ajani, Z. Ju, 2018, Nature Medicine.

Inhibition of DNA2 nuclease as a therapeutic strategy targeting replication stress in cancer cells

G. Peng, P. Sung, Surinder Kumar, 2017, Oncogenesis.